Literature DB >> 7005416

Varicella in children with renal transplants.

C M Feldhoff, H H Balfour, R L Simmons, J S Najarian, S M Mauer.   

Abstract

Nineteen of 160 children developed varicella between eight days and 6.4 years following renal transplantation. Eight had severe varicella characterized by prolonged fever and new vesicle formation with rash involving mucous membranes. The severe group had an increased incidence of thrombocytopenia and markedly elevated liver enzyme values. Two patients of this group had bladder paralysis and another died. In three children post-transplant varicella represented a second attack of the disease. Children maintained on azathioprine therapy for three days or more after onset tended to have severe varicella. No graft loss occurred consequent to stopping azathioprine. Children with transplants at risk should have zoster immune plasma or globulin upon exposure, and azathioprine therapy should be stopped at onset of varicella. Corticosteroid therapy should be continued in order to avoid stress-induced Addisonian crisis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7005416     DOI: 10.1016/s0022-3476(81)80527-6

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  21 in total

Review 1.  Herpesvirus infections in organ transplant recipients.

Authors:  Frank J Jenkins; David T Rowe; Charles R Rinaldo
Journal:  Clin Diagn Lab Immunol       Date:  2003-01

Review 2.  Aciclovir and varicella-zoster-immunoglobulin in solid-organ transplant recipients.

Authors:  Martina Prelog; Jörn Schönlaub; Lothar Bernd Zimmerhackl
Journal:  Pediatr Nephrol       Date:  2010-11-15       Impact factor: 3.714

Review 3.  Immunizations in solid organ and hematopoeitic stem cell transplant patients: A comprehensive review.

Authors:  Arnaud G L'Huillier; Deepali Kumar
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

4.  Should children in renal failure be immunised against chickenpox before receiving a renal transplant.

Authors:  R B Heath
Journal:  Pediatr Nephrol       Date:  1989-04       Impact factor: 3.714

5.  Live virus vaccines in transplantation: friend or foe?

Authors:  Charlotte M Verolet; Klara M Posfay-Barbe
Journal:  Curr Infect Dis Rep       Date:  2015-04       Impact factor: 3.725

Review 6.  Recent developments in dialysis and transplantation.

Authors:  D B Gradus; R N Fine
Journal:  Indian J Pediatr       Date:  1988 Jul-Aug       Impact factor: 1.967

7.  Immunisation against varicella in end stage and pre-end stage renal failure. Trans-Pennine Paediatric Nephrology Study Group.

Authors:  N J Webb; M M Fitzpatrick; D A Hughes; T J Brocklebank; B A Judd; M A Lewis; R J Postlethwaite; P A Smith; G Corbitt
Journal:  Arch Dis Child       Date:  2000-02       Impact factor: 3.791

8.  Impact and costs of varicella prevention in a university hospital.

Authors:  D J Weber; W A Rutala; C Parham
Journal:  Am J Public Health       Date:  1988-01       Impact factor: 9.308

Review 9.  The use of vaccines in renal failure.

Authors:  D W Johnson; S J Fleming
Journal:  Clin Pharmacokinet       Date:  1992-06       Impact factor: 6.447

10.  A spell of chicken-pox on a cancer patients' ward.

Authors:  R Eckstein; A Loy; U Jehn
Journal:  Klin Wochenschr       Date:  1984-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.